Former Real Housewives of Atlanta star Cynthia Bailey says that after gaining a few pounds, she turned to Ozempic…but that ...

Hims & Hers Health (NYSE: HIMS) is coming off a fantastic year in 2024 when its share price skyrocketed 172%. Is Hims & Hers ...

GoodRx CEO Wendy Barnes outlined the company's priorities at the 2025 JP Morgan Healthcare Conference in San Francisco.

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

Ozempic and Wegovy have become popular options for people looking to lose weight, but there are some risks and side effects ...

Here's a wrap-up of news on medicines and clinical treatments, including a win for the AMA, and updates from the TGA, PBS, and MBS, as well as ...

Robert F. Kennedy Jr. has reportedly secured the votes needed for confirmation as Secretary of Health and Human Services (HHS).

Annual treatments worth £6,000: Prescription hydrofacial, £1,000; Morpheus8, £1,300; Profhilo, £1,200; Botox, £760; Belotero ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 463.56% and ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...

These are the supplements we’re excited about and expect to see more of in 2025 If you're curious about what's trending in ...